Klebsiella LPS O1-antigen prevents complement-mediated killing by inhibiting C9 polymerization

Area of Science:

• Microbiology
• Immunology
• Molecular Biology

Background:

• Klebsiella pneumoniae is a significant human pathogen, with multi-drug resistant strains posing treatment challenges.
• The complement system is crucial for innate immunity, targeting Gram-negative bacteria via membrane attack complex (MAC) formation.
• Lipopolysaccharide (LPS) modification, particularly O-antigen decoration, is a known bacterial resistance mechanism, but its role in K. pneumoniae complement resistance is not fully understood.

Purpose of the Study:

• To investigate the role of LPS O-antigen in Klebsiella pneumoniae resistance to complement-mediated killing.
• To elucidate the molecular mechanisms by which O-antigen influences complement system interactions.

Main Methods:

• Characterization of clinical Klebsiella pneumoniae isolates with varying O-antigen expression.
• Analysis of complement component deposition (C3b, C5a, C6, C9) on bacterial surfaces.
• Investigation of membrane attack complex (MAC) pore formation and C9 polymerization.

Main Results:

• Expression of the LPS O1-antigen in K. pneumoniae correlates with increased resistance to complement-mediated killing.
• O1-antigen does not affect initial complement activation steps like C3b deposition or C5 conversion.
• O1-antigen facilitates C5a formation and C6/C9 deposition but hinders proper C9 polymerization and MAC insertion.

Conclusions:

• The LPS O1-antigen is a critical factor determining Klebsiella pneumoniae resistance to complement.
• O1-antigen mediates MAC evasion by interfering with C9 polymerization and pore formation.
• Understanding O1-antigen's role provides insights into K. pneumoniae pathogenesis and potential therapeutic targets.